G1 Therapeutics, Inc. financial data

Symbol
GTHX on Nasdaq
Industry
Pharmaceutical Preparations
Location
700 Park Offices Drive, Suite 200, Research Triangle Park, North Carolina
State of incorporation
Delaware
Fiscal year end
December 31
Former names
G-Zero Therapeutics, Inc. (to 4/18/2013)
Latest financial report
Q1 2024 - May 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 368 % -21%
Quick Ratio 41.6 % +0.22%
Debt-to-equity 208 % -1.4%
Return On Equity -74.8 % +66.5%
Return On Assets -24.3 % +66.1%
Operating Margin -27.2 % +86.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.3 M shares +1.2%
Common Stock, Shares, Outstanding 52.2 M shares +1.11%
Entity Public Float 128 M USD -39%
Common Stock, Value, Issued 5 K USD +25%
Weighted Average Number of Shares Outstanding, Basic 52.2 M shares +1.01%
Weighted Average Number of Shares Outstanding, Diluted 52.2 M shares +1.01%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 84 M USD +46.6%
Research and Development Expense 35.5 M USD -51%
Operating Income (Loss) -22.8 M USD +80.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -27.5 M USD +77.9%
Income Tax Expense (Benefit) 3.12 M USD +83.2%
Net Income (Loss) Attributable to Parent -30.6 M USD +75.7%
Earnings Per Share, Basic -0.6 USD/shares +78.3%
Earnings Per Share, Diluted -0.6 USD/shares +78.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19.9 M USD -70.9%
Marketable Securities, Current 45.3 M USD -5.78%
Accounts Receivable, after Allowance for Credit Loss, Current 11.7 M USD -27.3%
Inventory, Net 12.5 M USD -19.3%
Assets, Current 95.8 M USD -37.8%
Property, Plant and Equipment, Net 1.36 M USD -27%
Operating Lease, Right-of-Use Asset 4.63 M USD -18.9%
Assets 102 M USD -37%
Accounts Payable, Current 5.11 M USD -5.04%
Employee-related Liabilities, Current 1.58 M USD -24.9%
Accrued Liabilities, Current 17.9 M USD -21.5%
Liabilities, Current 32.6 M USD -3.23%
Operating Lease, Liability, Noncurrent 4 M USD -24.7%
Other Liabilities, Noncurrent 41 K USD
Liabilities 74.3 M USD -36.5%
Retained Earnings (Accumulated Deficit) -790 M USD -4.03%
Stockholders' Equity Attributable to Parent 27.7 M USD -38.3%
Liabilities and Equity 102 M USD -37%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.9 M USD +69.4%
Net Cash Provided by (Used in) Financing Activities -8.72 M USD -3976%
Net Cash Provided by (Used in) Investing Activities 5.29 M USD +81.8%
Common Stock, Shares Authorized 120 M shares 0%
Common Stock, Shares, Issued 52.3 M shares +1.11%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -12.3 M USD +53.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.82 M USD -27.4%
Deferred Tax Assets, Valuation Allowance 184 M USD +5.68%
Deferred Tax Assets, Gross 185 M USD +5.45%
Operating Lease, Liability 5.62 M USD -16.8%
Depreciation 890 K USD +62.7%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 6.53 M USD -20%
Operating Lease, Liability, Current 1.28 M USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.73 M USD +2.74%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.68 M USD +2.75%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 918 K USD -35.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.77 M USD +2.78%
Deferred Tax Assets, Operating Loss Carryforwards 121 M USD +2.32%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 3.12 M USD +83.2%
Preferred Stock, Shares Authorized 5 M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.36 M USD -23.5%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 0 USD
Current Federal Tax Expense (Benefit) 0 USD
Depreciation, Depletion and Amortization 120 K USD -9.09%
Share-based Payment Arrangement, Expense 13.2 M USD -29.2%
Deferred State and Local Income Tax Expense (Benefit) 0 USD